A Candidate Gene Study of CYP19 (Aromatase) and Male Sexual Orientation

被引:0
|
作者
Michael G. DuPree
Brian S. Mustanski
Sven Bocklandt
Caroline Nievergelt
Dean H. Hamer
机构
[1] National Cancer Institute,Laboratory of Biochemistry
[2] National Institutes of Health,Department of Anthropology
[3] Pennsylvania State University,Center for Neurobehavioral Genetics
[4] University of California,Department of Psychology
[5] Indiana University,Department of Psychiatry
[6] University of California,undefined
来源
Behavior Genetics | 2004年 / 34卷
关键词
Homosexuality; sexual orientation; aromatase; CYP19; linkage; expression;
D O I
暂无
中图分类号
学科分类号
摘要
Aromatase cytochrome P450 (CYP19), which is necessary for the conversion of androgens to estrogens, plays an important role in the sexual differentiation of the brain. To investigate whether differences in the gene encoding the aromatase enzyme influence sexual orientation in men, we conducted linkage, association, and expression analyses in a large sample of homosexual brothers using microsatellite markers in and around CYP19. No linkage was detected, and a gene-specific relative risk of 1.5-fold could be excluded at a lod score of −2. Results of the TDT demonstrated no preferential transmission of any of the CYP19 alleles in this sample. Expression of aromatase mRNA by microarray analysis was not significantly different between heterosexual and homosexual men. These results suggest that variation in the gene for this subunit of the aromatase enzyme complex is not likely to be a major factor in the development of individual differences in male sexual orientation.
引用
收藏
页码:243 / 250
页数:7
相关论文
共 50 条
  • [31] Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
    N Siegelmann-Danieli
    K H Buetow
    British Journal of Cancer, 1999, 79 : 456 - 463
  • [32] Characterization of a cetacean aromatase (CYP19) and the phylogeny and functional conservation of vertebrate aromatase
    Wilson, JY
    McArthur, AG
    Stegeman, JJ
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2005, 140 (01) : 74 - 83
  • [33] Study of the aromatase cytochrome P-450 gene (CYP19) promoter usage in osteoblasts cells.
    Enjuanes, A
    Garcia-Giralt, N
    Grinberg, D
    Balcells, S
    Supervia, A
    Bustamante, M
    Mellibovsky, L
    Nogues, X
    Diez-Perez, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S438 - S438
  • [34] Inhibition of human aromatase complex (CYP19) by antiepileptic drugs
    Jacobsen, N. W.
    Halling-Sorensen, B.
    Birkved, F. K.
    TOXICOLOGY IN VITRO, 2008, 22 (01) : 146 - 153
  • [35] Regulated CYP19 aromatase transcription in breast stromal fibroblasts
    Pauley, RJ
    Santner, SJ
    Tait, LR
    Bright, RK
    Santen, RJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02): : 837 - 846
  • [36] The Alternative Noncoding Exons 1 of Aromatase (Cyp19) Gene Modulate Gene Expression in a Posttranscriptional Manner
    Wang, Hanzhou
    Li, Rong
    Hu, Yanfen
    ENDOCRINOLOGY, 2009, 150 (07) : 3301 - 3307
  • [37] Daily Expression of Cyp19 Aromatase Gene is Altered in Mouse Leydig Tumor Cells and Clock Dependent in Male Reproductive Tract
    Neumann, A.
    Kotwica-Rolinska, J.
    Bebas, P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S152 - S153
  • [38] Induction of Fos in the accessory olfactory system by male odors persists in female mice with a null mutation of the aromatase (cyp19) gene
    Lau, YE
    Cherry, JA
    Baum, MJ
    Mani, SK
    BRAIN RESEARCH BULLETIN, 2003, 60 (1-2) : 143 - 150
  • [39] Expression of CYP19 (aromatase) mRNA in the human temporal lobe
    Stoffel-Wagner, B
    Watzka, M
    Steckelbroeck, S
    Schwaab, R
    Schramm, J
    Bidlingmaier, F
    Klingmüller, D
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (03) : 768 - 771
  • [40] Genetic variants of CYP19 (aromatase) and breast cancer risk
    V Nedelcheva Kristensen
    N Harada
    N Yoshimura
    E Haraldsen
    PE Lønning
    B Erikstein
    R Kåresen
    T Kristensen
    A-L Børresen-Dale
    Breast Cancer Research, 2 (Suppl 1)